Hematopoietic and Lymphatic System Neoplasm

Hematopoietic and Lymphatic System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 451–500 of 8,057 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04948333	Asciminib Treatment Optimization in ≥ 3rd Line CML-CP	completed	Phase 3	199	Novartis PharmaceuticalsINDUSTRY	16	Mar 18, 2026	clinicaltrials
NCT02135133	A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL	completed	Phase 2	27	Dana-Farber Cancer InstituteOTHER	1	Mar 17, 2026	clinicaltrials